Pulmonx Corp (LUNG) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
LUNG currently has 41.9M outstanding shares. with significant dilution risk as 169M authorized shares could dilute existing holders by 402.4%. The company has minimally diluted shareholders by 7.8% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 04, 2026 |
10-Q filing | 41.9M shares outstanding |
42M | 170M |
| Nov 24, 2025 |
S-3/A filing: Pulmonx Corporation may offer and sell up to an aggregate amount of $200,000,000 of any combination of common stock, preferred stock, debt securities and warrants. |
41M | 170M |
| Nov 12, 2025 |
10-Q filing | 40.9M shares outstanding |
41M | 170M |
| Aug 01, 2025 |
10-Q filing | 40.4M shares outstanding |
40M | 170M |
| May 02, 2025 |
10-Q filing | 40.0M shares outstanding |
40M | 170M |
| Feb 25, 2025 |
10-K filing | 39.1M shares outstanding |
39M | 170M |
| Nov 01, 2024 |
10-Q filing | 39.3M shares outstanding |
39M | 170M |
| Aug 02, 2024 |
10-Q filing | 38.9M shares outstanding |
39M | 170M |
| May 03, 2024 |
10-Q filing | 38.6M shares outstanding |
39M | 170M |
| Feb 27, 2024 |
10-K filing | 38.0M shares outstanding |
38M | 170M |
| Nov 03, 2023 |
10-Q filing | 38.1M shares outstanding |
38M | 170M |
| Aug 04, 2023 |
10-Q filing | 37.8M shares outstanding |
38M | 170M |
| May 08, 2023 |
10-Q filing | 37.6M shares outstanding |
38M | 170M |
| Mar 01, 2023 |
10-K filing | 37.1M shares outstanding |
37M | 170M |
| Nov 08, 2022 |
10-Q filing | 37.2M shares outstanding |
37M | 170M |
| Nov 03, 2022 |
S-3 filing: The filing is an S-3 registration statement for the potential offering of common stock, preferred stock, and/or debt securities, potentially through warrants, with terms to be determined by market conditions at the time of offering and detailed in a prospectus supplement. |
37M | 170M |
| Aug 08, 2022 |
10-Q filing | 37.0M shares outstanding |
37M | 170M |
| May 09, 2022 |
10-Q filing | 36.8M shares outstanding |
37M | 170M |
| Mar 01, 2022 |
10-K filing | 36.1M shares outstanding |
36M | 170M |
| Nov 09, 2021 |
10-Q filing | 36.4M shares outstanding |
36M | 170M |
| Aug 10, 2021 |
10-Q filing | 36.0M shares outstanding |
36M | 170M |
| May 12, 2021 |
10-Q filing | 36.2M shares outstanding |
36M | 170M |
| Mar 15, 2021 |
10-K filing | 35.7M shares outstanding |
36M | 170M |
| Nov 13, 2020 |
10-Q filing | 35.7M shares outstanding |
36M | 170M |
| Sep 30, 2020 |
S-1/A filing: S-1/A filing for offering of common stock. |
22M | 190M |
| Sep 28, 2020 |
S-1/A filing: This S-1/A filing details convertible promissory notes that will convert into common stock and issuances of Series F-1 and G-1 Preferred Stock to accredited investors under Section 4(a)(2) exemption. |
23M | 180M |
| Sep 24, 2020 |
S-1/A filing: S-1/A filing for an initial public offering of common stock. |
23M | 180M |
| Sep 04, 2020 |
S-1 filing: This S-1 filing describes an offering of common stock with the principal purposes of increasing financial flexibility, creating a public market for common stock, and facilitating future access to capital markets, with proceeds intended for sales and marketing, product development, and general corporate purposes, including a success fee payment to Oxford Finance LLC. |
200M | 0 |
| May 08, 2020 |
RW filing: Pulmonx Corporation is withdrawing its Registration Statement on Form S-1 (File No. 333-236762) because it has determined not to pursue the public offering to which the Registration Statement relates at this time. |
200M | 0 |
| Feb 28, 2020 |
S-1 filing: This is an initial public offering for shares of common stock. |
200M | 0 |